We previously found that ziram, a dithiocarbamate fungicide, significantly inhibited natural killer (NK) activity in a dose-dependent manner. To explore the mechanism of this inhibition, we investigated ziram-induced apoptosis in human NK cells. Human NK-92MI cells were treated with ziram at 0.0625-4 IlM for 2-64 h. Apoptosis was determined by FITC-Annexin-V/PI staining. To explore the mechanism of apoptosis, intracellular levels of active caspases 3, 3/7, 8, and 9 and pan-caspase and mitochondrial cytochrome-c release were determined by flow cytometry. Disruption to mitochondrial transmembrane potential was determined with a MitoLight™ Apoptosis Detection Kit. It was found that ziram induced apoptosis in a doseand time-dependent manner in human NK cells. Ziram increased the intracellular levels of active caspases 3, 3/7, 8, and 9 and pan-caspase in a dose-dependent manner, and a caspase-3 inhibitor, Z-DEVD-FMK, and a general caspase inhibitor, Z-VAD-FMK, partially but significantly inhibited the apoptosis. Ziram also disrupted mitochondrial transmembrane potential and caused mitochondrial cytochrome-c release in a dose-dependent manner. These findings indicate that ziram can induce apoptosis in human NK cells, and the apoptosis is at least mediated by both the caspase-cascade and the mitochondria/cytochrome-c pathways.
Fluorescein isothiocynate (FITC)-anti human Annexin V and FITC-anti human active caspase-3, Z-DEVD-FMK (a caspase-3 inhibitor), Z-VAD-FMK (a general caspase inhibitor), Z-FA-FMK (a negative control for Z-DEVD-FMK and Z-VAD-FMK), Cytofix/cytoperm solution, the APO-BRDU Apoptosis Detection Kit were purchased from BD Pharmingen (San Diego, CA, USA). CaspaTag Caspases 3/7, 8, 9 and Pan-Caspase In Situ Assay Kits and the Mitol.ight" Apoptosis Detection Kit were purchased from CHEMICON (Temecula, CA). Ziram was obtained from Wako Pure Chemical Industries (Osaka, Japan) and prepared as stock solutions in DMSO.
Cell line
The NK-92MI cell line was obtained from ATCC (Manassas, VA, USA) and was maintained in a-MEM without ribonucleosides and deoxyribonucleosides with 2 mM L-glutamine adjusted to contain 1.5 gIL sodium bicarbonate and supplemented with 0.2 mM inositol, 0.1 mM 2-ME, 0.02 mM folic acid, and 10% FBS at 37°C in a 5% CO 2 incubator. NK-92MI is an IL-2-independent NK cell line derived from NK-92 cells by transfection with human IL-2 eDNA (14) . The cell line expresses high levels ofthe CD56 surface marker and intracellular perforin, GrA, GrB, Gr3/K, and granulysin (6) (7) (8) (9) (10) , and is cytotoxic to a wide range of malignant cells, killing both K562 (6, (8) (9) (10) and Daudi (14) cells in chromium release assays.
Ziram-induced apoptosis and necrosis in NK-92MI cells determined by FITC-Annexin VIPIstaining
In Japan the residual standards for ziram in rice and potato are 0.3 and 0.2 ppm calculated as carbon disulfide, respectively
[http://ceis.sppd.ne.jp/fs2006/factsheet/ pdf/l-249.pdf (in Japanese)]. Thus, 0.0625-4 11M (approximately 0.02-1.25 ppm) of ziram was applied in the present study.
The NK-92MI cells at lx l Ovml were treated with ziram at 0 (0.1% DMSO), 0.0625, 0.125, 0.25, 0.5, 1,2, or 4 11M for 2, 4, 8, 16, 24, 48 or 64 h at 37°C in a 5% CO 2 incubator. The treated cells were stained with FITC-Annexin-V/PI, and 10,000 cells were acquired and stored for analysis with a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA) as described previously (9, 12, 13, 15, 16) . The solubility ofziram in water is 65 mg/l (65 ppm) (1) . The highest concentration of ziram used in the present study was 4 11M (1.25 ppm), suggesting that all ziram should be dissolved in the culture medium during the in vitro culture.
Determination of intracellular levels ofactive caspase-3 in NK-92MI cells byflow cytometry
NK-92MI cells at lx IO' Iml were incubated with ziram at 0 (0.1% DMSO), 0.0625, 0.125, 0.25, 0.5, I, 2 or 4 11M for 24 h at 37°C in a 5% C02 incubator, harvested, and washed twice with PBS. The cells were fixedlpermeabilized with Cytofix/cytoperm solution for 20 min at 4°C, and active caspase-3 was stained with FITC-anti human active caspase-3 for 30 min at room temperature according to the manufacturer's instructions (BD PharMingen). Again, the flow cytometric analysis was performed with FACScan (10,000 cells per analysis) (9, 12, 13, 15, 16) .
Determination of intracellular levels of active caspases 317, 8, and 9 and pan-caspase in NK-92MI cells with CaspaTag Caspase In Situ Assay Kits NK-92MI cells at IxlO 5 Iml were incubated with ziram at 0 (0.1% DMSO), 0.0625, 0.125, 0.25, 0.5, 1,2 or 4 11M for 24 h at 37°C in a 5% CO 2 incubator, harvested, and washed twice with PBS. Then, the cells positive for caspases 3/7, 8, and 9 and pan-caspase were stained with fluorochrome inhibitors of caspases (FLICA) and subjected to flow cytometry (10,000 cells per analysis) according to the manufacturer's instructions (12) (13) .
Protecting effects of caspase-3 and general caspase inhibitors on ziram-induced apoptosis in NK-92MI cells
NK-92MI cells at IxlO 5 Iml were preincubated with Z-DEVE-FMK, an inhibitor of caspase-3, Z-VAD-FMK, a general caspase inhibitor, or Z-FA-FMK, a negative control for Z-DEVE-FMK and Z-VAD-FMK, at 20 11M for 30 min, treated with ziram at 0 (0.1% DMSO), 2 11M for 24 h, and then harvested and washed twice with PBS. The treated cells were stained with FITC-Annexin-V/PL Flow cytometric analysis was performed with FACScan (10,000 cells per analysis) (9, 12, 13, 15, 16) .
Determination of the disruption of mitochondrial transmembrane potential with the Mitol.ight" Apoptosis Detection Kit
NK-92MI cells at IxlO 5 Iml were incubated with ziram at 0 (0.1% DMSO), 0.0625, 0.125, 0.25, 0.5, 1,2 or 4 11M for 24 h at 37°C in a 5% C02 incubator, harvested, and washed twice with PBS. The cells were stained with Mitol.ight" solution and detected by flow cytometry (10,000 cells per analysis) according to the manufacturer's instructions (12) (13) .
Analysis ofcytochrome-c release
NK-92MI cells at IxlO 5 Iml were incubated with ziram at 0 (0.1% DMSO), 0.0625, 0.125, 0.25, 0.5, I, 2 or 4 11M for 24 h at 37°C in a 5% CO 2 incubator, harvested, and washed twice with PBS. The cells were fixedlpermeablized with Cytofix/cytoperm solution for 20 min at 4°C, and the intracellular cytochrome-c was stained with FITC-anti human cytochrome-c (mouse IgG 1) or FITC-mouse IgG 1 as an isotypic control for 30 min at 4°C according to the manufacturer's instructions (eBioscience, San Diego, CA). Flow cytometric analysis was performed with FACScan (10,000 cells per analysis) (12) (13) 17) .
Statistical analyses.
The numbers of apoptotic cells, active caspase-positive cells and cytochrome-c-negative cells were used for statistical analyses. Statistical analyses were performed using one-way ANOVAs followed by a post hoc test, Tukey's test, with SPSS 16.0J software for Windows. A linear correlation analysis and paired t-test were also conducted. The significance level for p-values was set at < 0.05.
RESULTS

Ziram-induced apoptosis and necrosis in NK-92MI cells determined by FITC-Annexin-VIPI staining
As shown in Fig Fig. 1C , there was almost no difference between 2 and 4 flM, suggesting that the maximal effective concentration for the induction of apoptosis should be 2 flM. In addition, the percentage of apoptotic cells treated with ziram at 48 h were higher than that or similar to that at 64 h, suggesting that the peak time for the induction of apoptosis should be 48 h ( Fig. IC and IE) .
Detection of intracellular levels of active caspase-3 in apoptotic NK-92MI cells by flow cytometry
Based on the results shown in Fig. I , we incubated the cells for 24 h to investigate the effect of ziram on caspases, cytochrome-c and mitochondrial transmembrane potential in subsequent experiments.
To explore the mechanism of the apoptosis, we investigated whether ziram affected the intracellular level of active caspase-3. As shown in Fig. 2 , ziram induced a significant increase in active caspase-3 in a dose-dependent manner. However, there was almost no difference between 2 and 4 flM, suggesting that the maximal effective concentration for activation of caspase-3 should be 2 flM. Moreover, an inhibitor of active caspase-3 significantly protected against the apoptosis (Fig. 4) . We have confirmed that caspase inhibitors did not exhibit more significant anti-apoptotic properties when the apoptosis rate in control experiment was increased to 60-70%. The findings suggest that ziram induced apoptosis at least partially via the caspase-3 pathway.
Detection ofcaspases 317, 8, and 9 andpan-caspase in apoptotic NK-92MI cells with CaspaTag Caspase In Situ Assay Kits
To explore whether other caspases were also involved in the ziram-induced apoptosis, we investigated the intracellular levels ofactive caspases 3/7,8, and 9 and pan-caspase in NK-92MI cells. As shown in Fig. 3 , ziram induced significant increases in active caspases 3/7, 8, and 9 and pan-caspase in a dose-dependent manner. Caspases 3/7 and pancaspase were more sensitive to ziram than caspases 8 and 9. However, there was almost no difference between 2 and 4 flM, suggesting that the maximal effective concentration for activation of caspases should be 2 flM. Moreover, a general inhibitor of caspases significantly protected against the apoptosis (Fig. 4) . The findings suggest that ziram induced apoptosis at least partially via the caspase cascade pathway.
Determination of the disruption of mitochondrial transmembrane potential with the Mitol.ight" Apoptosis Detection Kit
To further investigate whether the mitochondrial pathway was also involved in the ziram-induced apoptosis of NK-92MI cells, we determined mitochondrial transmembrane potential with the Mitol.ight" Apoptosis Detection Kit. We found that ziram disrupted the transmembrane potential in a dose-dependent manner. However, the cells with the disruption of the transmembrane potential at 4 flM were less than those at 2 flM, suggesting that the maximal effective concentration for the disruption of the transmembrane potential should be 2 flM (Fig. 5 ).
Detection of mitochondrial cytochrome-c release in apoptotic NK-92MI cells by flow cytometry
To further explore the mechanism of ziraminduced apoptosis in NK-92MI cells, we investigated suggesting that the maximal effective concentration for the induction of cytochrome-c release should be l/lM.
DISCUSSION
We previously found that ziram significantly inhibited NK activity (6) . To explore the mechanism of this inhibition, we investigated whether ziram induces apoptosis/necrosis in human NK cells. In the present study, we found that ziram at a very low concentration (0.125 /lM) induced apoptosis in a dose-and time-dependent manner in a human NK cell line, the NK-92MI cells. In addition, it also induced necrosis in a dose-and time-dependent manner in NK-92MI cells. This is the first report on ziram-induced apoptosis in human NK cells, although it has been reported that ziram induced apoptosis in human monocytes and T cells (12) (13) .
The caspase family of cysteine proteases plays a key role in apoptosis. Caspase-3 is a key protease and an effector/executioner caspase activated during the early stages of apoptosis and is synthesized as an inactive proenzyme that is processed in cells undergoing apoptosis by self-proteolysis and/or cleavage by another protease such as caspase 8 or 9 (18) (19) .
Based on this background, we investigated the effect of ziram on caspase-3 to explore the mechanism of ziram-induced apoptosis. We found a significant increase in the intracellular level of active caspase-3 in NK-92MI cells. Moreover, Z-DEVD-FMK, a caspase-3 inhibitor, significantly inhibited the apoptosis. These findings suggested that ziram induces apoptosis at least via the caspase-3 pathway. However, the caspase-3 inhibitor only partially prevented the apoptosis, suggesting other pathways to be involved. Caspases 7 is also an effector/ executioner caspase (19) . Caspases 8 and 9 are also synthesized as inactive pro-caspases that are processed in cells undergoing apoptosis by selfproteolysis and/or cleavage by another protease (18) . Caspase-8 is an initiator of apoptosis and procaspase-3 is a major physiologic target of caspase-8 (20) . Caspase-9 is also an initiator of apoptosis in the mitochondria/cytochrome-c pathway and active caspase-9 directly cleaves and activates pro-caspase-3 (21) . Based on this background, we investigated the effects of ziram on caspases 3/7, 8, and 9 and found that ziram significantly increased their intracellular levels in a dose-dependent manner. Moreover, we also found that ziram significantly increased the intracellular levels ofactive pan-caspase in a dose-dependent manner and that Z-VAD-FMK, a general caspase .inhibitor, significantly blocked the zirarri-induced apoptosis indicating the involvement of all caspases (caspase cascade) in ziram-induced apoptosis in NK-92MI cells. We previously found that ziram significantly activated the caspases in human T cells (13) ; however, the patterns differed between human T cells and NK cells. All caspases (caspases 317, 8, 9, and pan-caspase) showed a similar sensitivity to ziram and a general caspase inhibitor almost completely blocked the ziraminduced apoptosis in human T cells (13) ; however, in human NK cells, caspases 317 and pan-caspase were more sensitive to ziram than caspases 8 and 9 (Fig. 3) and a general caspase inhibitor only partially prevented the apoptosis (Fig. 4 ), suggesting the different mechanisms between NK and T cells in ziram-induced apoptosis. Disruption of mitochondrial transmembrane potential is one of the earliest intracellular events to occur following the induction of apoptosis (22) . Ziram disrupted the transmembrane potential in NK-92MI cells in a dose-dependent manner determined by Mitol.ight" Apoptosis Detection Kit, suggesting that ziram also affects the mitochondrial pathway.
Cytochrome-c initiates apoptosis through its release into the cytoplasm and binding of Apaf-I which activates procaspase 9 (22) . The release of cytochrome-c from mitochondria was a very early event during apoptosis (23) . Based on this background, we also investigated the effects of ziram on cytochrome-c release to explore the mechanism of ziram-induced apoptosis. Ziram produced a significantly higher proportion of cells without cytochome-c in a dose-dependent manner, indicating that the release of cytochrome-c from mitochondria was induced by ziram. This finding also suggested that cytochrome-c was involved in the apoptosis. Taken together, the findings suggested that ziram affects both the caspase-cascade and the mitochondrialcytochrome-c pathways.
Moreover, because the Fas/Fas ligand pathway is an important trigger for apoptosis and upstream of caspase 8 activation (24) , the effect of ziram on the Fas/FasL should also be considered. Therefore, a study to investigate the influence of ziram on the Fas/FasL pathway is necessary in the future.
Sook et al. (25) reported that ziram induced apoptosis in PCl2 cells via Ca{2+) influx through nonselective cation channels. Wang et al. (26) found that ziram-induced cell death in SK-N-MC neuroblastoma cells was closely correlated with proteasomal inhibition, but not correlated with the cellular production of reactive oxygen species, suggesting that cellular oxidative stress was not a mechanism of ziram-induced cell death. Moreover, Chou et al. (27) also found that ziram causes dopaminergic cell damage by inhibiting EI ligase in the proteasome, suggesting that inhibition of the proteasome is a potential mechanism of ziram-induced cell death. However, they did not identify whether ziraminduced cell death consisted ofapoptosis (26) (27) . We also previously found that ziram induced apoptosis in human monocytes and T cells partially mediated by the activation of intracellular caspases and the release of cytochrome-c from mitochondria (12) (13) .
Taken together, the present findings indicate that ziram can induce apoptosis in human NK cells, and the apoptosis is at least mediated by both the caspase-cascade and the mitochondrialcytochrome-c pathways.
